Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro

Cystinosis is a rare disease caused by homozygous mutations of the CTNS gene, encoding a cystine efflux channel in the lysosomal membrane. In Ctns knockout mice, the pathologic intralysosomal accumulation of cystine that drives progressive organ damage can be reversed by infusion of wildtype bone marrow-derived stem cells, but the mechanism involved is unclear since the exogeneous stem cells are rarely integrated into renal tubules. Here we show that human mesenchymal stem cells, from amniotic fluid or bone marrow, reduce pathologic cystine accumulation in co-cultured CTNS mutant fibroblasts or proximal tubular cells from cystinosis patients. This paracrine effect is associated with release into the culture medium of stem cell microvesicles (100–400 nm diameter) containing wildtype cystinosin protein and CTNS mRNA. Isolated stem cell microvesicles reduce target cell cystine accumulation in a dose-dependent, Annexin V-sensitive manner. Microvesicles from stem cells expressing CTNSRed transfer tagged CTNS protein to the lysosome/endosome compartment of cystinotic fibroblasts. Our observations suggest that exogenous stem cells may reprogram the biology of mutant tissues by direct microvesicle transfer of membrane-associated wildtype molecules.

[1]  G. Camussi,et al.  MicroRNAs and mesenchymal stem cells. , 2011, Vitamins and hormones.

[2]  D. Hwang,et al.  Proteomic analysis of microvesicles derived from human colorectal cancer ascites , 2011, Proteomics.

[3]  L. Kluijtmans,et al.  Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. , 2011, Biochimica et biophysica acta.

[4]  J. Koziol,et al.  Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. , 2011, Kidney international.

[5]  J. Rak,et al.  Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’ , 2011, Seminars in Immunopathology.

[6]  D. Martineau,et al.  Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. , 2010, American journal of physiology. Renal physiology.

[7]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[8]  G. Camussi,et al.  Stem Cells , Tissue Engineering and Hematopoietic Elements Stem Cells Derived from Human Amniotic Fluid Contribute to Acute Kidney Injury Recovery , 2010 .

[9]  K. Meldrum,et al.  Therapeutic applications of mesenchymal stem cells to repair kidney injury. , 2010, The Journal of urology.

[10]  J. Jester,et al.  Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. , 2009, Blood.

[11]  J. Rak,et al.  Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.

[12]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[13]  R. Kerbel,et al.  Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.

[14]  J. Kurtzberg,et al.  Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. , 2008, Blood.

[15]  W. Gahl,et al.  Nephropathic cystinosis: late complications of a multisystemic disease , 2008, Pediatric Nephrology.

[16]  L. Mannucci,et al.  Identification and subcellular localization of a new cystinosin isoform. , 2008, American journal of physiology. Renal physiology.

[17]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[18]  H. Kwon,et al.  Proteomic analysis of microvesicles derived from human colorectal cancer cells. , 2007, Journal of proteome research.

[19]  W. Gahl,et al.  Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy , 2007, Annals of Internal Medicine.

[20]  J. Thoene,et al.  Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta. , 2006, Journal of the American Society of Nephrology : JASN.

[21]  V. Baekelandt,et al.  Comparison of lentiviral vector titration methods , 2006, BMC biotechnology.

[22]  C. Antignac,et al.  Cystinosin, the protein defective in cystinosis, is a H+‐driven lysosomal cystine transporter , 2001, The EMBO journal.

[23]  G. Striker,et al.  Early development of the renal lesions in infantile cystinosis , 2000, Pediatric Nephrology.

[24]  E. Green,et al.  Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). , 1999, Molecular genetics and metabolism.

[25]  D. Rosenblatt,et al.  Novel reductant for determination of total plasma homocysteine. , 1997, Clinical chemistry.

[26]  W. Gahl,et al.  Improved renal function in children with cystinosis treated with cysteamine. , 1993, The New England journal of medicine.

[27]  J. Schulman,et al.  Effects of cysteamine and other thiols on cystine egress from isolated lysosome-rich fractions of cystinotic and normal leucocytes. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[28]  W. Gahl,et al.  Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. , 1982, Science.

[29]  W. Gahl,et al.  Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. , 1982, The Journal of biological chemistry.

[30]  T. Triche,et al.  Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Triche,et al.  Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. , 1982, The New England journal of medicine.

[32]  C. W. Hall,et al.  Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured Fibroblasts , 1968, Science.

[33]  J. Seegmiller,et al.  Transport and Intracellular Fate of Cysteine-35S in Leukocytes from Normal Subjects and Patients with Cystinosis , 1968, Pediatric Research.

[34]  J. Seegmiller,et al.  Increased Cystine in Leukocytes from Individuals Homozygous and Heterozygous for Cystinosis , 1967, Science.